243 related articles for article (PubMed ID: 10881330)
1. Familial polycythemia due to truncations of the erythropoietin receptor.
Forget BG; Degan BA; Arcasoy MO
Trans Am Clin Climatol Assoc; 2000; 111():38-44; discussion 44-5. PubMed ID: 10881330
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
3. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
4. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene.
Arcasoy MO; Degar BA; Harris KW; Forget BG
Blood; 1997 Jun; 89(12):4628-35. PubMed ID: 9192789
[TBL] [Abstract][Full Text] [Related]
5. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
7. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis.
Arcasoy MO; Karayal AF; Segal HM; Sinning JG; Forget BG
Blood; 2002 Apr; 99(8):3066-9. PubMed ID: 11929803
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state.
Watowich SS; Xie X; Klingmuller U; Kere J; Lindlof M; Berglund S; de la Chapelle A
Blood; 1999 Oct; 94(7):2530-2. PubMed ID: 10498627
[TBL] [Abstract][Full Text] [Related]
10. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
[TBL] [Abstract][Full Text] [Related]
12. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
13. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.
Sokol L; Luhovy M; Guan Y; Prchal JF; Semenza GL; Prchal JT
Blood; 1995 Jul; 86(1):15-22. PubMed ID: 7795221
[TBL] [Abstract][Full Text] [Related]
14. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
[TBL] [Abstract][Full Text] [Related]
16. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.
Ammarguellat F; Llovera M; Kelly PA; Goffin V
Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898
[TBL] [Abstract][Full Text] [Related]
17. [Proliferative signal transmission mediated by EpoR in leukemic cell lines].
Fan H; Kanji S; Zhai M
Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995
[TBL] [Abstract][Full Text] [Related]
18. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
[TBL] [Abstract][Full Text] [Related]
19. Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene.
Divoky V; Liu Z; Ryan TM; Prchal JF; Townes TM; Prchal JT
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):986-91. PubMed ID: 11158582
[TBL] [Abstract][Full Text] [Related]
20. The distal cytoplasmic domain of the erythropoietin receptor induces granulocytic differentiation in 32D cells.
Harris KW; Hu XJ; Schultz S; Arcasoy MO; Forget BG; Clare N
Blood; 1998 Aug; 92(4):1219-24. PubMed ID: 9694710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]